GFAP and Alzheimer disease: Our finding of elevated GFAP in APOE4 carriers is consistent with experiments in human iPSC-derived astrocytes showing that APOE4 is a key driver of low-grade chronic inflammation and exacerbated responses to cytokine stimuli that recapitulate the AD environment(18).